Recent Company News

• 05:18 PM ET Apr 06, 2026
  

  StreetAccount Scorecard: Weekly performance of the FTSE China Index sectors (ending 3-Apr)

• 05:12 PM ET Apr 01, 2026
  

  Asymchem Laboratories (Tianjin) upgraded to buy from underperform at BofA (CNY 121.85, 0.00)

• 10:03 AM ET Mar 30, 2026
  

  Asymchem Laboratories (Tianjin) reports FY net income attributable CNY1.13B vs FactSet CNY1.13B [15 est, CNY1.09-1.19B] (CNY 100.70, 0.00)

• 10:19 PM ET Feb 05, 2026
  

  Goldman Sachs upgrades 2268.HK, 2359.HK, 603259.CH; downgrades 002821.CH, 1513.HK, 1521.HK, others (pre-Asian open)

• 03:22 PM ET Jan 28, 2026
  

  Asymchem Laboratories (Tianjin) initiated buy at Kaiyuan Securities

• 05:12 AM ET Oct 30, 2025
  

  Asymchem Laboratories (Tianjin) reports Q3 net income attributable CNY182.8M, (13.5%) y/y (CNY 102.53, 0.00)

• 05:41 AM ET Sep 11, 2025
  

  Asymchem Laboratories (Tianjin) initiated outperform at Guosen Securities (timing uncertain) (CNY 109.96, 0.00)

• 11:37 PM ET Sep 09, 2025
  

  StreetAccount Summary - Trading higher/lower: China mid-morning

• 10:01 PM ET Sep 01, 2025
  

  Asymchem Laboratories (Tianjin) upgraded to strong recommend at China Merchants Securities; prior rating was overweight (1-Sep, timing uncertain) (CNY 111.50, +0.72)

• 10:04 PM ET Aug 31, 2025
  

  Asymchem Laboratories (Tianjin) initiated recommend at Founder Securities (29-Aug, timing uncertain) (CNY 108.15, +1.23)